Literature DB >> 33770519

WHO International Standard for anti-SARS-CoV-2 immunoglobulin.

Paul A Kristiansen1, Mark Page2, Valentina Bernasconi1, Giada Mattiuzzo2, Peter Dull3, Karen Makar3, Stanley Plotkin4, Ivana Knezevic5.   

Abstract

Entities:  

Year:  2021        PMID： 33770519      PMCID： PMC7987302          DOI： 10.1016/S0140-6736(21)00527-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  108 in total

1.  Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients.

Authors:  Matthieu Giot; Toscane Fourié; Guillaume Lano; Paola Mariela Saba Villarroel; Xavier de Lamballeri; Marion Gully; Laurent Samson; Julien Farault; Dammar Bouchouareb; Océane Jehel; Philippe Brunet; Noémie Jourde-Chiche; Laetitia Ninove; Thomas Robert
Journal:  Clin Kidney J       Date:  2021-07-06

2.  SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses.

Authors:  Maria E Montez-Rath; Pablo Garcia; Jialin Han; LinaCel Cadden; Patti Hunsader; Curt Morgan; Russell Kerschmann; Paul Beyer; Mary Dittrich; Geoffrey A Block; Julie Parsonnet; Glenn M Chertow; Shuchi Anand
Journal:  J Am Soc Nephrol       Date:  2022-08-16       Impact factor: 14.978

3.  Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination.

Authors:  Franziska Neumann; Ruben Rose; Janine Römpke; Olaf Grobe; Thomas Lorentz; Helmut Fickenscher; Andi Krumbholz
Journal:  Vaccines (Basel)       Date:  2021-06-25

Review 4.  Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2.

Authors:  Ian McDonald; Sam M Murray; Catherine J Reynolds; Daniel M Altmann; Rosemary J Boyton
Journal:  NPJ Vaccines       Date:  2021-05-13       Impact factor: 7.344

5.  Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.

Authors:  Alexey A Komissarov; Inna V Dolzhikova; Grigory A Efimov; Denis Y Logunov; Olga Mityaeva; Ivan A Molodtsov; Nelli B Naigovzina; Iuliia O Peshkova; Dmitry V Shcheblyakov; Pavel Volchkov; Alexander L Gintsburg; Elena Vasilieva
Journal:  J Immunol       Date:  2022-01-31       Impact factor: 5.422

6.  Humoral immune response after different SARS-CoV-2 vaccination regimens.

Authors:  Ruben Rose; Franziska Neumann; Olaf Grobe; Thomas Lorentz; Helmut Fickenscher; Andi Krumbholz
Journal:  BMC Med       Date:  2022-01-21       Impact factor: 8.775

7.  The CEPI centralised laboratory network: supporting COVID-19 vaccine development.

Authors:  Arun Kumar; Valentina Bernasconi; Mark Manak; Ana Paula de Almeida Aranha; Paul A Kristiansen
Journal:  Lancet       Date:  2021-06-05       Impact factor: 79.321

8.  Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?

Authors:  Giuseppe Lippi; Brandon Michael Henry; Mario Plebani
Journal:  Diagnostics (Basel)       Date:  2021-05-25

9.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

10.  Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab.

Authors:  Antonio Gallo; Rocco Capuano; Giovanna Donnarumma; Alvino Bisecco; Elena Grimaldi; Miriana Conte; Alessandro d'Ambrosio; Nicola Coppola; Massimiliano Galdiero; Gioacchino Tedeschi
Journal:  Neurol Sci       Date:  2021-06-15       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.